The synthesis of peptide−polymer conjugates comprising ( d - alt - l )-cyclopeptides as aggregator domains and their self-assembly into tubelike structures is described. By coupling two well-defined poly( n -butyl acrylate) blocks to opposite sides of a preformed cyclic ( d - alt - l )-α-octapeptide, a coil−ring−coil bioconjugate was accessed. The applied solution-phase coupling route allowed a multigram scale synthesis of the conjugate and assured both a controlled synthesis and ease of analysis. The controlled self-assembly of the conjugate leads to uniform tube structures. Atomic force microscopy (AFM) of these aggregates deposited on mica revealed a height of 1.4 ± 0.2 nm, a width of 5 nm, and roughly estimated lengths of up to 200−300 nm. A model is proposed, explaining the structure dimensions. This includes the formation of a tubular peptide core build via stacking of the cyclopeptides and a poly( n -butyl acrylate) shell wrapping around the peptide tube. The model is consistent with infrared spectroscopy and electron diffraction measurements, verifying that the peptide segment of the conjugate adopts a β-sheet structure, similar to unsubstituted ( d - alt - l )-cyclopeptides. Hence, the stacks of peptide rings are stabilized along the fiber axis via inter-ring β-sheet H-bonding. The tube structures are capable to interact laterally, organizing further into weak networks as was evidenced by AFM and transmission electron microscopy.
No takes yet. Share an insight, caveat, or question.
Cate et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: